OpenAlex
PricingAboutJobs
Log inGet started
Work

Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study

HTML

Year: 2020
Type: article
Study design: Observational Study
Source: Diabetes Care
DOI: 10.2337/dc19-2088
Authors: Björn Pasternak, Viktor Wintzell, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Mads Melbye, Henrik Svanström, Peter Ueda
Institutions: Statens Serum Institut, Karolinska Institutet, University of Gothenburg, Norwegian University of Science and Technology, University of Copenhagen, Stanford Medicine, Stanford University
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, renal replacement therapy, DPP-4 inhibitors, liraglutide, exenatide, lixisenatide, dulaglutide, type 2 diabetes, renal mortality, drug safety, real-world evidence, propensity score matching, as-treated analysis, type 1 diabetes
SDG: Good health and well-being

Open Access status: closed

Funders: Cancerfonden, Svenska Sällskapet för Medicinsk Forskning, Hjärt-Lungfonden, Karolinska Institutet, Novo Nordisk Fonden
Award: G1879928664
OpenAlex ID: W3016916224
FWCI: 6.43
Cites: 33
Cited by: 74
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security